Stocks snapped a two-day winning streak Wednesday after tepid reports on employment and the services sector. Pfizer, Merck and Home Depot were the biggest decliners on the Dow.
On Wednesday, disappointing earnings sent investors running for the exits stopping a comeback dead in its tracks. Is the correction back; what should you be watching?
Stocks struggled Wednesday after tepid reports on employment and the services sector.
The ADP report for January, at a loss of 22,000 jobs (consensus was for a loss of 30,000), was the smallest decline since January 2008, which was the last time there was jobs growth. Then there's dividends — lots of dividends.
Stocks were set to ease slightly at the opening, following the S&P's best two-day gain since October. But numbers on the employment landscape will likely dictate early sentiment.
Stocks on Wall Street could be put to the test Wednesday, after the market notched its best two-day gain in four months.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
Stocks turned a shaky start into a full-throttle rally Tuesday as UPS delivered an encouraging earnings report, pending home sales rose and Ford reported a double-digit increase in sales.
Nearly every city and state wants biopharma. They fiercely compete for the relatively clean industry and the well-paid, highly educated jobs it brings.
The week started out with nothing but good looking news. Overseas a bunch of countries reported their Purchasing Managers surveys (PMI) and they were almost uniformly good.
Pfizer, the world's largest drugmaker, is scheduled to report fourth-quarter results before the opening bell on Wednesday, February 3. Here is a look at how Pfizer shares traded during the most recent earnings reports.
Considering Pfizer, Sanofi and Glaxo are among the many Pharma names reporting this week, how should you game the space?
Markets started the new month higher, but how long can the trend continue? Art Cashin, director of floor operations at UBS Financial Services, shared his insights.
Brace for another round of big earnings, next week. And options action suggests Exxon, Cisco and Pfizer are poised to move.
First we found out bacon makes you smarter. Now, it may also make you sexier. Oh, bacon. Is there anything you can't do?
As earnings season comes to its midway point, Cramer put together a list of 20 February 2010 earnings reports. So, what are the most important earnings reports to watch?
Three out of four prescriptions in the U.S. are filled with generics. But a new, albeit small, survey by a prominent generic drug industry analyst shows even the people filling those pill bottles have issues with generics.
Markets opened mixed on Thursday. What should investors expect from stocks going forward? Ray Harrison, founder of Harrison Financial Group, and Bill Smead, CEO and CIO of Smead Capital Management, shared their investment plays.
Traders are coming to the realization that corporate America presented their most exciting earnings reports first in this earnings season.
If your investment strategy is ‘slow and steady wins the race,’ Pete Najarian has a trade for you.